Neuropathy
|
0.100 |
Biomarker
|
group |
BEFREE |
Our study delineates CMT1C as mostly a mild form of neuropathy, and gives clinical and electrophysiological clues differentiating CMT1C from CMT1A and HNPP.
|
28211240 |
2017 |
Neuropathy
|
0.100 |
Biomarker
|
group |
BEFREE |
CMT is a group of heterogeneous motor and sensory neuropathies divided into demyelinating (CMT1) and axonal forms (CMT2).
|
26989944 |
2016 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The Pro132Leu mutation segregates with a severe early-onset dysmyelinating-hypomyelinating neuropathy, whereas the Ile135Thr substitution is associated with the classical phenotype of CMT1.
|
21107784 |
2011 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Charcot-Marie-Tooth disease (CMT) is a group of clinically and genetically heterogeneous neuropathies classically divided into demyelinating (CMT1) and axonal forms (CMT2).
|
20537790 |
2010 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Hereditary motor and sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth disease (CMT) is a group of clinically and genetically heterogeneous neuropathies classically divided into demyelinating (CMT1) and axonal forms (CMT2).
|
19344920 |
2009 |
Neuropathy
|
0.100 |
Biomarker
|
group |
BEFREE |
Most demyelinating forms of Charcot-Marie-Tooth type 1 (CMT1) neuropathy are slowly progressive and do not respond to anti-inflammatory treatment.
|
15261606 |
2004 |
Neuropathy
|
0.100 |
Biomarker
|
group |
BEFREE |
We conclude that DSS, although in general denoting a more serious neuropathy than CMT1, does not imply a severe disability or wheelchair dependency in adult life.
|
12090401 |
2002 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
X-linked Charcot-Marie-Tooth neuropathy (CMTX), which has clinical features similar to CMT1, is associated with mutations in the connexin32 gene.
|
11345007 |
2001 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
X-linked Charcot-Marie-Tooth neuropathy (CMTX), which has clinical features similar to CMT1, is associated with mutations in the connexin32 gene.
|
10716658 |
1999 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
X-linked Charcot-Marie-Tooth neuropathy (CMTX), which has clinical features similar to CMT1, is associated with mutations in the connexin32 gene.
|
10219749 |
1999 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Genetic heterogeneity within the most common genetic neuropathy, Charcot-Marie-Tooth disease (CMT) results in about 70% slow nerve conduction CMT1 and 30% normal nerve conduction CMT2.
|
8135298 |
1993 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Two major types can be distinguished based on electrophysiologic phenotypes: CMT type 1 (CMT1) displays uniformly decreased nerve conduction velocity associated with a demyelinating hypertrophic neuropathy, and CMT type 2 (CMT2) displays normal or near-normal nerve conduction velocity associated with a neuronal defect.
|
8128981 |
1993 |
Neuropathy
|
0.100 |
GeneticVariation
|
group |
BEFREE |
In this study we excluded all four regions for the presence of distal HMN II, indicating that this neuropathy is genetically different from CMT 1 and recessive SMA.
|
1517763 |
1992 |